Oncology Institute (TOI) Change in Cash (2020 - 2026)

Oncology Institute has reported Change in Cash for 7 years, with the latest figure at -$3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 66.92% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$9.5 million (down 356.76% YoY), and the FY2025 full-year result was -$16.1 million, down 199.52% from the prior year.
• Change in Cash for Q1 2026 stood at -$3.3 million, down from $5.9 million in the prior quarter.
• The five-year high for Change in Cash was $13.6 million in Q2 2023, with the low at -$47.4 million in Q4 2022.
• Historically, Change in Cash has averaged -$5.0 million across 5 years, with a median of -$1.4 million in 2023.
• Annual changes were most pronounced in 2024 — Change in Cash jumped 908.99% — and 2025, when it slumped 2660.16%.
• Oncology Institute's Change in Cash stood at -$47.4 million in 2022, then soared by 112.56% to $6.0 million in 2023, then sank by 61.92% to $2.3 million in 2024, then soared by 160.56% to $5.9 million in 2025, then sank by 155.61% to -$3.3 million in 2026.
• The last three Change in Cash figures came in at -$3.3 million (Q1 2026), $5.9 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.